IMMUNIC (IMUX) Director Elena Ridloff Receives 50,740-Share Award

What Happened

• Elena Ridloff, a director of IMMUNIC, Inc. (IMUX), was granted 50,740 derivative shares (reported as an award/acquisition) on 2026-08-06. The reported price per share is $0.00, indicating no cash paid at grant. This is an acquisition-type award (not a sale).

Key Details

• Transaction date: 2026-08-06; Form 4 filed: 2026-08-10 (see filing accession 0001193805-26-001069).
• Security/amount: 50,740 derivative shares awarded; reported price $0.00 per share.
• Vesting: Footnote F1 — the options vest in monthly increments over three years from the grant date.
• Shares owned after transaction: not specified in the summary provided (check the Form 4 for the insider’s post-transaction beneficial ownership).
• Filing timeliness: the Form 4 lists the filing date; review the filing for any late-filing indicator if timing is a concern.

Context

• This transaction is an award/grant of derivative securities (footnote describes an options-style vesting schedule). Such grants commonly tie compensation to long-term performance; they do not necessarily represent an immediate market purchase or sale.